Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research led by the Centre for Tropical Medicine and Global Health, involving a new finger-prick blood test (C-reactive protein) to help nurses and doctors decide whether their patients need antibiotic treatment.

A superbug crisis has arisen because microbes are becoming increasingly resistant to antibiotics and other antimicrobials. Yet, patients’ lifestyles, cultural beliefs around illness and treatment, and the vast diversity of public, private, and unregulated healthcare providers were common barriers to accessing or correctly understanding the test.

Read the full article

Similar stories

Developing the world's first lung cancer vaccine

Researchers at the Nuffield Department of Medicine, the Francis Crick Institute and University College London have been granted £1.7 million of funding from Cancer Research UK and the CRIS Cancer Foundation to develop a lung cancer vaccine. The group includes Professor Tim Elliott, Kidani Professor of Immuno-oncology at NDM.